Drug :: New Critical Path Report Highlights Research Needed to Foster Generic Drug Development
The U.S. Food and Drug Administration (FDA) issued the “Critical Path Opportunities for Generic Drugs” report identifying many of the unanswered scientific questions that impede the development of generic versions of commonly used drugs.